About 2 results found for searched term "BM213" (0.12 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M25151 | Beludavimab | Anti-infection |
| BMS 4182137; VIR 7832 | ||
| Beludavimab (BMS 4182137; VIR 7832) is a monoclonal antibody targeting the spike glycoprotein of SARS-CoV-2. Beludavimab binds to recombinant spike protein receptor-binding domain (S-RBD) with an EC50 value of 14.9 ng/mL and a Kd of 0.21 nM. | ||
| M54074 | BM213 | Others |
| BM213, a potent and selective agonist for C5aR1, shows antitumor activity in a mouse model of mammary carcinoma. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
